TapImmune Inc. (NASDAQOTH:TPIV)

CAPS Rating: 1 out of 5

Results 1 - 4 of 4

Recs

0
Member Avatar TSIF (99.95) Submitted: 1/21/2016 11:21:33 AM : Underperform Start Price: $0.63 TPIV Score: -12.42

What Jed71 said.

Add that spends about half of each stock raise each quarter, so has managed to bank a buck or two. This should provide the one employee some income for awhile, but some paper debt is still more than the cash.

Also wonder why the expense to issue shares to your friends and family incurred a 20% expense....
Just wait until some of the low price ones mature and see who in the "family" sells first....

Nice Gig.

Target: 0.20 or less...

Recs

0
Member Avatar RES7 (99.35) Submitted: 12/17/2015 10:05:10 PM : Underperform Start Price: $0.63 TPIV Score: -10.30

jed71

Recs

3
Member Avatar jed71 (99.85) Submitted: 12/14/2015 1:47:49 PM : Underperform Start Price: $0.68 TPIV Score: -2.87

Do you ever think to yourself, "my company is just NOT issuing enough warrants for my taste. I really think we should have a series E warrant, just to, ya know, mix things up." Well, have no fear, for TPIV is here!!!

"NOTE 8: CAPITAL STOCK 2015 Share Transactions Private placements In January, 2015, the Company entered into a Securities Purchase Agreement with certain investors for the sale of 7,320,000 units at a purchase price of $0.20 per unit, for a total purchase price of approximately $1,250,000, net of finders' fee and offering expenses of approximately $214,000. Each unit consisting of (i) one share of the Company's Common Stock, (ii) one Series A warrant to purchase one share of common stock, (iii) one Series B warrant to purchase one share of common stock (iv) one Series C warrant to purchase one share of common stock, (v) one Series D warrant to purchase one share of common stock, and (vi) one Series E warrant to purchase one share of common stock (the Series A, B, C, D and E warrants are hereby collectively referred to as the "January 2015 Warrants"). Series A warrants are exercisable at $1.50 per share, with a five year term. Series B warrants are exercisable at $0.40 per share, with a six month term. Series C warrants are exercisable at $1.00 per share, with a five year term. Series D warrants are exercisable at $0.75 per share only if and to the extent that the Series B warrants are exercised, with a five year term from the date that the Series B warrants are exercised. Series E warrants are exercisable at $1.25 per share, only if and to the extent that the Series C warrants are exercised, with a five year term from the date that the Series C warrants are exercised."

If your stock is trading at $0.67 a share, and the company has somewhat recently issued new shares at 70% lower to market, run away. FAST. And don't look back.

Recs

1
Member Avatar TMFStockSpam (99.97) Submitted: 2/18/2010 10:30:54 AM : Underperform Start Price: $46.00 TPIV Score: +186.45

This stock spam was originally sent to TMFPhila:

TapImmune Inc.

Syimbol: TPIV

Currrent Value: $0.47
Shorrt Term Tarrget: $1.25
Lonng Term Tarrget: $4.30

TapImmune Inc. is a biotechnology company specializing in the development of innovative cell based immunotherapeutics and vaccines in the areas of cancer and infectious disease.
The Company's lead product candidate, the AdhTAP vaccine enhancer is designed to restore and augment antigen presentation and subsequent recognition and killing of cancer cells by the immune system.

The Company is also developing a TAP based prophylactic vaccine which initial tests indicate may increase the efficacy of targeted prophylactic vaccines by up to 1000 times.

All eyes are going to be on this Winner with a Major Awareness campaign shifting into top gear.

Keep it on your radar!

Results 1 - 4 of 4

Featured Broker Partners